The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Dec. 07, 2015
Applicants:

Barbara Haeberlin, Munchenstein, DE;

Frank Stowasser, Murg, DE;

Wolfgang Wirth, Arisdorf, CH;

Anton Baumberger, Binningen, CH;

Stephan Abel, Weil am Rhein, DE;

Sebastian Kaerger, Riehen, CH;

Thomas Kieckbusch, Lorrach, DE;

Inventors:

Barbara Haeberlin, Munchenstein, DE;

Frank Stowasser, Murg, DE;

Wolfgang Wirth, Arisdorf, CH;

Anton Baumberger, Binningen, CH;

Stephan Abel, Weil am Rhein, DE;

Sebastian Kaerger, Riehen, CH;

Thomas Kieckbusch, Lorrach, DE;

Assignee:

Novartis AG, Basel, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01); A61K 31/40 (2006.01); A61K 45/06 (2006.01); A61K 47/12 (2006.01);
U.S. Cl.
CPC ...
A61K 9/1617 (2013.01); A61K 9/0075 (2013.01); A61K 9/145 (2013.01); A61K 9/1688 (2013.01); A61K 31/40 (2013.01); A61K 45/06 (2013.01); A61K 47/12 (2013.01);
Abstract

A process for preparing dry powder formulations of a glycopyrronium salt for inhalation that have good stability. The process involves (a) micronising a glycopyrronium salt together with an anti-adherent agent, and (b) admixing carrier particles to form the dry powder formulation.


Find Patent Forward Citations

Loading…